The future of the global joint repair market is in sports medicine, point-of-care tests and robotic assisted surgeries, according to a report from P&S Market Research.
Spinal Tech
Kalamazoo, Mich.-based Stryker is extending the range of its settlement program to include patients who underwent procedures to remove the recalled implants since Nov. 3, 2014.
Salt Lake City-based Amedica Corp. reported positive study results, demonstrating rapid bone growth into porous silicon nitride.
Cambridge, Mass.-based InVivo Therapeutics enrolled a new patient into its INSPIRE study, which tests the Neuro-Spinal Scaffold's efficacy and safety for complete thoracic AIS A spinal cord injury.
The global cervical total disc replacement device market is expected to grow at a compound annual growth rate of 23.1 percent between 2015 and 2021.
Advertisement
Stryker CEO Kevin Lobo appeared on CNBC's Squawk CEO Call to discuss several aspects of the business and where his company is headed in the future.
Walnut Creek, Calif.-based Providence Medical Technology closed a new equity financing round of $10.5 million.
Farmingdale, N.Y.-based Misonix named Stavros G. Vizirgianakis the new president and CEO, effective immediately, according to StreetInsider.com.
Matthew Link, San Diego-based NuVasive's president of U.S. commercial, sold 10,303 company shares on Dec. 12, 2016, according to The Market Digest.
Mark Richards, Director of Marketing Communications, Events and Services at Zimmer Biomet Spine, discusses the company's two major acquisitions of 2016 and where Zimmer Biomet plans to grow in the spine space going forward.